SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Riley Griffin
Tech
Meta gains after Zuckerberg predicts ‘really big year’ in AI
By
Riley Griffin
and
Bloomberg
Politics
Bernie Sanders grills Ozempic maker over high prices, accuses company of endangering lives
By
Madison Muller
,
Naomi Kresge
, and others
Health
Federal health agency gives cannabis industry a big lift by endorsing looser drug rules for marijuana
By
Jonathan Roeder
,
Riley Griffin
, and others
Health
Biden administration pushes Walgreens, CVS and Walmart to tout drug cost benefits of Inflation Reduction Act as drugmakers sue government
By
Riley Griffin
and
Bloomberg
Health
Declassified report shows Covid-19 origins remain a mystery, despite Wuhan lab researchers falling sick in 2019
By
Riley Griffin
and
Bloomberg
Finance
You have until May 31 to order free COVID tests before the federal government ends the program after mailing 750 million kits
By
Riley Griffin
and
Bloomberg
Biden to spur biomanufacturing, reduce reliance on China with executive order
By
Riley Griffin
and
Bloomberg
Health
Americans will have to pay for COVID vaccines and treatments as soon as January because Congress has run out of money to buy them
By
Riley Griffin
,
Alexander Ruoff
, and others
Health
Johnson & Johnson to stop selling talc-based baby powder as cancer lawsuits pile on
By
Riley Griffin
,
Jef Feeley
, and others
Health
Fauci to retire before end of Biden’s current term after five decades of working in government
By
Riley Griffin
,
Jeannie Baumann
, and others
Health
Pfizer says three COVID shots is ‘highly effective’ in children under 5
By
Riley Griffin
and
Bloomberg
International
Pfizer pauses clinical trials in Russia, says it will continue to send drugs to patients
By
Riley Griffin
and
Bloomberg
Finance
The COVID bump looks over for Pfizer as 2022 forecast falls short of Wall Street estimates, stock drops
By
Riley Griffin
and
Bloomberg
Health
Pfizer is testing a hybrid COVID vaccine, mixing its original with a new formulation that shields against Omicron
By
Riley Griffin
and
Bloomberg
Health
Johnson & Johnson turn to influencers for help in reaching Gen-Z shoppers
By
Riley Griffin
,
Kim Bhasin
, and others